MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.thromres.2025.109358

Медицинская библиотека · Thrombosis research · 2025

Exploring the role of inflammation and proinflammatory proteins in coagulopathy during venovenous extracorporeal membrane oxygenation.

Wang Ya, Sun Huadong, Zhang Jie, Xie Xiaowen, Yu Yuheng, Liang Zhenting, Ye Weiyan, Zeng Zitao, Luo Xinyi, Liu Dongdong, Xi Yin, Zhang Rong, Yang Chun, Zhou Liang, Li Manshu, Pan Jieyi, Xu Zhiheng, Sang Ling, Xu Yuanda, He Weiqun, Zhang Haibo, Liu Xiaoqing, Li Yimin, Xu Yonghao

СтатьяПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

BACKGROUND

Coagulopathy frequently complicates venovenous extracorporeal membrane oxygenation (VV ECMO) procedures, yet its underlying mechanism remains elusive. This retrospective study aimed to identify factors contributing to coagulopathy during VV ECMO by analyzing clinical data and employing proteomic approaches. A prospective cohort was also examined for validation.

METHODS

We retrospectively analyzed clinical data from 51 patients undergoing VV ECMO between January 2015 and April 2021, categorizing them into coagulopathy(n = 21), defined by elevated levels of D-dimer and decreased fibrinogen in plasma that were reversible by circuit exchange, and non-coagulopathy(n = 30) groups. Plasma samples collected on days 0-2(D1), days 3-5(D4), and days 6-8(D7) were subjected to proteomics and Luminex assay. Additionally, oxygenator fiber samples were collected from a prospective cohort between May 2022 and August 2022 for scanning electron microscopy.

RESULTS

Inflammation emerged as a pivotal factor in coagulopathy development during VV ECMO, as evidenced by elevated interleukin-6 levels on D1 and increased leukocyte and neutrophil counts on D4. Proteomics analysis identified a significant elevation of S100A8 and S100A9 in the plasma of coagulopathy patients throughout VV ECMO, findings confirmed by Luminex assay. In the prospective cohort, thrombosis and leukocyte accumulation were observed on oxygenator fibers from coagulopathy patients, along with elevated levels of S100A8 and S100A9 in plasma.

CONCLUSIONS

Coagulopathy during VV ECMO is associated with heightened levels of proinflammatory proteins S100A8 and S100A9 in plasma, accompanied by leukocyte accumulation on oxygenator fibers. These findings emphasize the potential therapeutic target against coagulopathy during VV ECMO.

Для цитирования: Wang Ya, Sun Huadong, Zhang Jie, Xie Xiaowen, Yu Yuheng, Liang Zhenting, Ye Weiyan, Zeng Zitao, Luo Xinyi, Liu Dongdong, Xi Yin, Zhang Rong, Yang Chun, Zhou Liang, Li Manshu, Pan Jieyi, Xu Zhiheng, Sang Ling, Xu Yuanda, He Weiqun, Zhang Haibo, Liu Xiaoqing, Li Yimin, Xu Yonghao. Exploring the role of inflammation and proinflammatory proteins in coagulopathy during venovenous extracorporeal membrane oxygenation.. Thrombosis research. 2025. DOI: 10.1016/j.thromres.2025.109358.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.